Veritas Research Foundation
Current Fiscal Year
Fiscal Year Start Date: January 1, 2026
Fiscal Year End Date: December 31, 2026
Projected Revenue: $0
Projected Expense: $10,000
Revenue vs. Expense ($)
Expense Breakdown: 2024 (%)
| Administration Expense | 0.0% |
| Program Expense | 0.0% |
| Fundraising Expense | 0.0% |
Expense Breakdown: 2023 (%)
| Administration Expense | 0.0% |
| Program Expense | 0.0% |
| Fundraising Expense | 0.0% |
Expense Breakdown: 2022 (%)
| Administration Expense | 0.0% |
| Program Expense | 0.0% |
| Fundraising Expense | 0.0% |
990 Tax Form
Prior Three Years Total Revenue and Expense Totals
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Revenue | $35,043 | $45,646 | $76,194 |
| Total Expenses | $28,464 | $6,718 | $2,375 |
Prior Three Years Revenue Sources
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Foundation and Corporation Contributions | - | - | - |
| Government Contributions | - | - | - |
| Federal | - | - | - |
| State | - | - | - |
| Local | - | - | - |
| Unspecified | - | - | - |
| Individual Contributions | - | - | - |
| Indirect Public Support | - | - | - |
| Earned Revenue | - | - | - |
| Investment Income, Net of Losses | - | - | - |
| Membership Dues | - | - | - |
| Special Events | - | - | - |
| Revenue In-Kind | - | - | - |
| Other Revenue | - | - | - |
Prior Three Years Expense Allocations by Type
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Program Expense | - | - | - |
| Administration Expense | - | - | - |
| Fundraising Expense | - | - | - |
| Payments to Affiliates | - | - | - |
| Total Revenue/Total Expenses | 1.23 | 6.79 | 32.08 |
| Program Expense/Total Expenses | - | - | - |
| Fundraising Expense/Total Revenue | - | - | - |
Prior Three Years Assets and Liabilities
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | - | $112,747 | $73,819 |
| Current Assets | - | - | - |
| Long-Term Liabilities | - | - | - |
| Current Liabilities | - | - | - |
| Total Net Assets | $119,326 | - | - |
Short Term Solvency
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets/Current Liabilities | - | - | - |
Long Term Solvency
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Long Term Liabilities/Total Assets | - | - | - |
Endowment/Capital Campaigns
Are you currently in a Capital Campaign? Yes
Capital Campaign Purpose:
Raise $2 million to fund Pharmacovigilance 2.0, Veritas Research Foundation’s independent program to detect, confirm, and prevent medication-related harm in older adults. Funds will support Phase I analyses of the most commonly used outpatient medications in a national Medicare cohort of nearly 10 million beneficiaries—including data access, analytic infrastructure, and peer-reviewed publication—so clinicians and regulators can prescribe more safely. VRF does not accept pharmaceutical industry funding.
Campaign Goal: $2,000,000
Capital Campaign Start Date: January 1, 2026
Capital Campaign End Date: December 31, 2027
Capital Campaign Raised-to-Date Amount: $0
CONTACT
Veritas Research Foundation
4030 CALLE MARLENA
SAN CLEMENTE, CA 92672-4514
Christopher G. Rowan
Phone: 3109186530